GlassScriptPhysician profile
Richard Novack
NPI 1699971705
$143,844.88
in general payments reported to CMS, 2019-2025
15 companies · $249 in 2025
The $249 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $44.73 · 2021: $49K · 2022: $42K · 2023: $43K · 2024: $9,011 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $44K · Food and Beverage: $3,515 · Travel and Lodging: $2,855 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $44,000.00 |
| Food and Beverage | $3,515.08 |
| Travel and Lodging | $2,854.82 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $141,994.08 | 2020-2025 | Da Vinci Surgical System, Davinci Xi, Da Vinci Sp |
| Lexington Medical, INC. | $789.20 | 2022-2024 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Medtronic, INC. | $182.12 | 2022-2023 | Ligasure |
| Lucid Diagnostics INC. | $162.25 | 2022-2023 | |
| Levita Magnetics International Corp | $156.02 | 2019 | |
| Gilead Sciences, INC. | $119.55 | 2022 | |
| Baxter Healthcare | $103.63 | 2019-2024 | Tisseel |
| Ethicon US, LLC | $80.31 | 2019-2022 | |
| Novo Nordisk INC | $72.21 | 2019-2025 | Wegovy |
| Phathom Pharmaceuticals, INC. | $52.64 | 2024-2025 | Voquezna |
| Olympus America INC. | $38.20 | 2019-2020 | |
| Covidien LP | $26.88 | 2019 | |
| Intra-Sana Laboratories | $26.06 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Tela Bio, INC. | $21.91 | 2024 | Ovitex 2s |
| Davol INC. | $19.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Novack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.